Genentech Biooncology
Genentech Biooncology
    • Home 

    • Research Education 

    • Research Apoptosis 

    • Apoptosis 

    • GLOSSARY
    • ON
    • OFF
  • Print
  • share
 
 
' The related resources bookmark allows you to jump directly to other pages on the site that contain information directly related to the topics you're currently exploring.
  • Home Page
  • What's New?
  • Tumor Types
  • Molecular Causes of Cancer
  • Biological Pathways
  • Therapeutic Targets
  • Pipeline Molecules
  • Research Education
    • Research ADCs
    • Research Apoptosis
      • Apoptosis
      • Resisting apoptosis
      • Apoptotic pathways
      • The Bcl-2 family
      • Reactivating apoptosis
      • Useful resources
      • References
      • Glossary
    • Research B cell
    • Research BRAF
    • Research Cancer Immunotherapy
    • Research HDIs
    • Research HER Pathways
    • Research MET
    • Research VEGF
  • Clinical Trials
  • Resources
  • Contact Us
Register for Updates Unsubscribe Share
Register for Updates Unsubscribe Share

Related Resources for this page:

  • Molecular Causes of Cancer
    • Growth Signaling
      • Evading growth suppressors
      • Sustaining proliferative signaling
    • Genome instability and mutation
    • Evading immune destruction
    • Inducing angiogenesis
    • Tumor-promoting inflammation
    • Activating invasion and metastasis
    • Enabling replicative immortality
    • Reprogramming energy metabolism
    • Resisting cell death
  • Biological Pathways
    • Apoptosis
  • Therapeutic Targets
    • Bcl-2
  • Future Directions
    • Antibody-Drug conjugates
      • HER Signaling
      • Receptor-Mediated Endocytosis
      • Glossary
      • Emerging therapeutic options
      • Emerging therapeutic options
    • Apoptosis
      • Emerging therapeutic options
    • Bispecific Monoclonal Antibodies
      • Emerging therapeutic options
      • Emerging therapeutic options
      • Emerging therapeutic options
    • Glycoengineered Antibodies
      • HER Signaling
      • Emerging therapeutic options
      • Emerging therapeutic options
      • Emerging therapeutic options
    • Non-Antibody Biologics
      • Apoptosis
      • Extrinsic pathway
    • Targeted Small Molecules
      • Apoptosis
      • MAPK Signaling
      • PI3K/Akt/mTOR Signaling
      • MEK Inhibitor (GDC-0973)
      • PI3K Inhibitor (GDC-0941)
      • Glossary
      • Emerging therapeutic options
      • Emerging therapeutic options
      • Emerging therapeutic options
      • Gastric Cancer
    • Traditional Monoclonal Antibodies
      • B-cell Surface Proteins
      • HER Signaling
      • Direct cell death
      • Emerging therapeutic options
      • Emerging therapeutic options
      • Emerging therapeutic options
      • Glossary
      • Gastric Cancer

Apoptosis video

Video

View the apoptosis mode of action video

View video
Share

Apoptosis: a critical process in homeostasis

In order for a cellular environment to maintain homeostasis, there needs to be a balance between cell life and cell death. If cell death is occurring too often or not often enough, it can disrupt homeostasis and lead to a variety of diseases, including cancer.4

Programmed cell death occurs mainly as a result of apoptosis, autophagy, and necrosis.5 Apoptosis, however, is the most common way the body eliminates damaged or unneeded cells without local inflammation from cell leakage.6,7

Apoptosis plays an important role throughout life, from embryonic development to adult tissue homeostasis.1 During embryonic development, neural apoptosis helps sculpt the brain.8 In adults, homeostasis maintains health by balancing cell death with cell proliferation.1

Cells that undergo apoptosis exhibit a characteristic pattern of morphologic changes, including cell shrinkage, condensation, fragmentation of the nucleus, and bubbling of the plasma membrane, known as “blebbing” (Image 1.1).7,9

Blebbing Image 1.1. A closer look at a cell undergoing apoptosis.
Enlarge this image

The malfunction of apoptosis is a key hallmark of cancer and is critical for cancer development and tumor-cell survival. Such health implications underscore the potential of using therapeutic strategies to manipulate apoptosis.1,2

 
  • SITEMAP
  • /
  • PRIVACY POLICY
  • /
  • TERMS & CONDITIONS
  • /
  • CONTACT US
  • /
  • © 2013 Genentech USA, Inc. All rights reserved.
  • /
  • BIO0000907901
Next section: Resisting apoptosis »

© 2011 Genentech USA, Inc. All rights reserved